Akash Tewari
Stock Analyst at Jefferies
(3.14)
# 1,220
Out of 4,413 analysts
43
Total ratings
42.86%
Success rate
3.02%
Average return
Main Sectors:
24 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Maintains: Buy | $42 → $50 | $24.01 | +108.25% | 2 | Apr 9, 2024 | |
| APGE Apogee Therapeutics | Maintains: Buy | $37 → $75 | $50.91 | +47.32% | 4 | Mar 6, 2024 | |
| APLS Apellis Pharmaceuticals | Upgrades: Buy | $68 → $80 | $46.05 | +73.72% | 1 | Feb 5, 2024 | |
| SYRE Spyre Therapeutics | Initiates: Buy | $31 | $33.87 | -8.47% | 1 | Dec 11, 2023 | |
| ARVN Arvinas | Upgrades: Buy | $32 → $40 | $32.48 | +23.15% | 2 | Dec 6, 2023 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $935 → $937 | $903.48 | +3.71% | 4 | Nov 28, 2023 | |
| SLRN Acelyrin | Maintains: Buy | $15 → $12 | $4.25 | +182.35% | 2 | Nov 28, 2023 | |
| PFE Pfizer | Upgrades: Buy | $38 → $39 | $27.18 | +43.49% | 2 | Oct 16, 2023 | |
| LLY Eli Lilly | Upgrades: Buy | $615 | $776.75 | -20.82% | 4 | Aug 9, 2023 | |
| ENTA Enanta Pharmaceuticals | Downgrades: Hold | $49 → $18 | $13.56 | +32.74% | 2 | Aug 8, 2023 | |
| ARGX argenx SE | Maintains: Buy | $497 → $513 | $383.34 | +33.82% | 2 | Jul 17, 2023 | |
| TERN Terns Pharmaceuticals | Initiates: Buy | $18 | $5.08 | +254.33% | 1 | Jun 7, 2023 | |
| RLAY Relay Therapeutics | Upgrades: Hold | $16 → $13 | $6.66 | +87.69% | 2 | Apr 20, 2023 | |
| MRK Merck & Co. | Initiates: Buy | $125 | $128.80 | -2.95% | 1 | Mar 6, 2023 | |
| BMY Bristol-Myers Squibb Company | Initiates: Hold | $62 | $44.21 | +40.24% | 1 | Mar 6, 2023 | |
| ZYME Zymeworks | Upgrades: Buy | $7.7 → $11 | $8.76 | +25.57% | 1 | Dec 20, 2022 | |
| THRD Third Harmonic Bio | Downgrades: Hold | $30 → $3.6 | $11.38 | -68.37% | 2 | Dec 16, 2022 | |
| ACRV Acrivon Therapeutics | Initiates: Buy | $17 | $8.23 | +106.56% | 1 | Dec 12, 2022 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $100 → $120 | $83.33 | +44.01% | 1 | Nov 29, 2022 | |
| NBIX Neurocrine Biosciences | Assumes: Buy | $112 | $143.03 | -21.69% | 1 | Jun 6, 2022 | |
| CYTK Cytokinetics | Initiates: Buy | n/a | $63.37 | - | 2 | Oct 7, 2021 | |
| MDGL Madrigal Pharmaceuticals | Initiates: Buy | n/a | $210.59 | - | 1 | Oct 7, 2021 | |
| EXEL Exelixis | Initiates: Buy | n/a | $21.93 | - | 2 | Oct 7, 2021 | |
| BNTX BioNTech SE | Initiates: Hold | n/a | $89.95 | - | 1 | Oct 7, 2021 |
Alkermes
Apr 9, 2024
Maintains: Buy
Price Target: $42 → $50
Current: $24.01
Upside: +108.25%
Apogee Therapeutics
Mar 6, 2024
Maintains: Buy
Price Target: $37 → $75
Current: $50.91
Upside: +47.32%
Apellis Pharmaceuticals
Feb 5, 2024
Upgrades: Buy
Price Target: $68 → $80
Current: $46.05
Upside: +73.72%
Spyre Therapeutics
Dec 11, 2023
Initiates: Buy
Price Target: $31
Current: $33.87
Upside: -8.47%
Arvinas
Dec 6, 2023
Upgrades: Buy
Price Target: $32 → $40
Current: $32.48
Upside: +23.15%
Regeneron Pharmaceuticals
Nov 28, 2023
Maintains: Buy
Price Target: $935 → $937
Current: $903.48
Upside: +3.71%
Acelyrin
Nov 28, 2023
Maintains: Buy
Price Target: $15 → $12
Current: $4.25
Upside: +182.35%
Pfizer
Oct 16, 2023
Upgrades: Buy
Price Target: $38 → $39
Current: $27.18
Upside: +43.49%
Eli Lilly
Aug 9, 2023
Upgrades: Buy
Price Target: $615
Current: $776.75
Upside: -20.82%
Enanta Pharmaceuticals
Aug 8, 2023
Downgrades: Hold
Price Target: $49 → $18
Current: $13.56
Upside: +32.74%
argenx SE
Jul 17, 2023
Maintains: Buy
Price Target: $497 → $513
Current: $383.34
Upside: +33.82%
Terns Pharmaceuticals
Jun 7, 2023
Initiates: Buy
Price Target: $18
Current: $5.08
Upside: +254.33%
Relay Therapeutics
Apr 20, 2023
Upgrades: Hold
Price Target: $16 → $13
Current: $6.66
Upside: +87.69%
Merck & Co.
Mar 6, 2023
Initiates: Buy
Price Target: $125
Current: $128.80
Upside: -2.95%
Bristol-Myers Squibb Company
Mar 6, 2023
Initiates: Hold
Price Target: $62
Current: $44.21
Upside: +40.24%
Zymeworks
Dec 20, 2022
Upgrades: Buy
Price Target: $7.7 → $11
Current: $8.76
Upside: +25.57%
Third Harmonic Bio
Dec 16, 2022
Downgrades: Hold
Price Target: $30 → $3.6
Current: $11.38
Upside: -68.37%
Acrivon Therapeutics
Dec 12, 2022
Initiates: Buy
Price Target: $17
Current: $8.23
Upside: +106.56%
BioMarin Pharmaceutical
Nov 29, 2022
Maintains: Buy
Price Target: $100 → $120
Current: $83.33
Upside: +44.01%
Neurocrine Biosciences
Jun 6, 2022
Assumes: Buy
Price Target: $112
Current: $143.03
Upside: -21.69%
Cytokinetics
Oct 7, 2021
Initiates: Buy
Price Target: n/a
Current: $63.37
Upside: -
Madrigal Pharmaceuticals
Oct 7, 2021
Initiates: Buy
Price Target: n/a
Current: $210.59
Upside: -
Exelixis
Oct 7, 2021
Initiates: Buy
Price Target: n/a
Current: $21.93
Upside: -
BioNTech SE
Oct 7, 2021
Initiates: Hold
Price Target: n/a
Current: $89.95
Upside: -